Key epilepsy gene gets further phenotypic delineation
Citation Manager Formats
Make Comment
See Comments
This article requires a subscription to view the full text. If you have a subscription you may use the login form below to view the article. Access to this article can also be purchased.
In this issue of Neurology®, a study from a neurogenetics group in Belgium1 traces the genetic defect in a 4-generation Bulgarian family with febrile seizures and epilepsy associated with varying degrees of cognitive impairment related to a microdeletion encompassing the SCN1A gene. Typically, SCN1A mutations that predict truncation or a highly abnormal protein (including microdeletions) are associated with severe childhood epileptic encephalopathies, specifically the syndrome of severe myoclonic epilepsy of infancy (SMEI or Dravet syndrome) and related disorders.2,3
Dravet syndrome is an epileptic encephalopathy with low reproductive fitness due to the usual outcome of moderate to severe intellectual disability and increased mortality in childhood. The novelty in the report by Suls et al.1 is the fact that the epileptic syndrome and the associated intellectual disability were not so severe to prevent procreation, which is counter to other currently published cases with such microdeletions. The observations are framed in the context of Dravet syndrome, which is the usual consequence of haploinsufficiency of SCN1A, whether due to a truncation mutation …
AAN Members
We have changed the login procedure to improve access between AAN.com and the Neurology journals. If you are experiencing issues, please log out of AAN.com and clear history and cookies. (For instructions by browser, please click the instruction pages below). After clearing, choose preferred Journal and select login for AAN Members. You will be redirected to a login page where you can log in with your AAN ID number and password. When you are returned to the Journal, your name should appear at the top right of the page.
AAN Non-Member Subscribers
Purchase access
For assistance, please contact:
AAN Members (800) 879-1960 or (612) 928-6000 (International)
Non-AAN Member subscribers (800) 638-3030 or (301) 223-2300 option 3, select 1 (international)
Sign Up
Information on how to subscribe to Neurology and Neurology: Clinical Practice can be found here
Purchase
Individual access to articles is available through the Add to Cart option on the article page. Access for 1 day (from the computer you are currently using) is US$ 39.00. Pay-per-view content is for the use of the payee only, and content may not be further distributed by print or electronic means. The payee may view, download, and/or print the article for his/her personal, scholarly, research, and educational use. Distributing copies (electronic or otherwise) of the article is not allowed.
Letters: Rapid online correspondence
REQUIREMENTS
You must ensure that your Disclosures have been updated within the previous six months. Please go to our Submission Site to add or update your Disclosure information.
Your co-authors must send a completed Publishing Agreement Form to Neurology Staff (not necessary for the lead/corresponding author as the form below will suffice) before you upload your comment.
If you are responding to a comment that was written about an article you originally authored:
You (and co-authors) do not need to fill out forms or check disclosures as author forms are still valid
and apply to letter.
Submission specifications:
- Submissions must be < 200 words with < 5 references. Reference 1 must be the article on which you are commenting.
- Submissions should not have more than 5 authors. (Exception: original author replies can include all original authors of the article)
- Submit only on articles published within 6 months of issue date.
- Do not be redundant. Read any comments already posted on the article prior to submission.
- Submitted comments are subject to editing and editor review prior to posting.
You May Also be Interested in
Long-term Safety and Efficacy of Avalglucosidase Alfa in Patients With Late-Onset Pompe Disease
Dr. Marianne de Visser and Dr. Maudy Theunissen
► Watch
Related Articles
Topics Discussed
Alert Me
Recommended articles
-
Articles
Genotype–phenotype associations in SCN1A-related epilepsiesS.M. Zuberi, A. Brunklaus, R. Birch et al.Neurology, January 19, 2011 -
Articles
Spectrum of SCN1A mutations in severe myoclonic epilepsy of infancyR. Nabbout, E. Gennaro, B. Dalla Bernardina et al.Neurology, June 24, 2003 -
Articles
Sodium channel α1-subunit mutations in severe myoclonic epilepsy of infancy and infantile spasmsR. H. Wallace, B. L. Hodgson, B. E. Grinton et al.Neurology, September 22, 2003 -
Brief Communications
A new molecular mechanism for severe myoclonic epilepsy of infancy: Exonic deletions in SCN1AJ. C. Mulley, P. Nelson, S. Guerrero et al.Neurology, September 25, 2006